ms 857 and Cardiac Failure
ms 857 has been researched along with Cardiac Failure in 2 studies
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Iwase, M; Nagata, K; Sobue, T; Yokota, M | 1 |
Kaiho, T; Kamiya, J; Kobari, T; Maruyama, M | 1 |
Trials
1 trial(s) available for ms 857 and Cardiac Failure
Article | Year |
---|---|
Differential effects of dobutamine and a phosphodiesterase inhibitor on early diastolic filling in patients with congestive heart failure.
Topics: Administration, Oral; Blood Flow Velocity; Cardiac Catheterization; Coronary Circulation; Diastole; Dobutamine; Echocardiography, Doppler, Pulsed; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Isoquinolines; Male; Middle Aged; Phosphodiesterase Inhibitors; Tetrahydroisoquinolines; Ventricular Function, Left | 1995 |
Other Studies
1 other study(ies) available for ms 857 and Cardiac Failure
Article | Year |
---|---|
Cardiovascular properties of MS-857, a new and potent cardiotonic agent, on normal and failing hearts.
Topics: Anesthesia; Animals; Cardiotonic Agents; Dogs; Female; Heart; Heart Failure; Isoquinolines; Lung; Male; Myocardium; Pentobarbital; Phosphoric Diester Hydrolases; Propranolol; Sodium-Potassium-Exchanging ATPase; Stereoisomerism; Tetrahydroisoquinolines | 1988 |